Subscribe To
ALVO / Teva Pharmaceuticals and Alvotech expand biosimilars partnership
ALVO News
By GlobeNewsWire
August 22, 2023
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, annou more_horizontal
By Market Watch
July 24, 2023
Teva Pharmaceuticals and Alvotech expand biosimilars partnership
Teva Pharmaceuticals Industries Ltd. TEVA, +0.47% and Alvotech ALVO, +0.51% announced Monday that they are expanding their collaboration in the U.S. b more_horizontal
By The Motley Fool
June 30, 2023
Why Shares of Alvotech Are Jumping Friday
Alvotech specializes in biosimilar medicines. The company received a complete response letter from the FDA regarding the manufacturing facility for it more_horizontal
By Seeking Alpha
June 8, 2023
Alvotech: Precarious Cash Position Dilutes Special Situation Opportunity
Alvotech has a resolvable CRL. This took down the stock, but when resolved, that could create a quick spike. Ordinarily, this would be an opportunity, more_horizontal
By Zacks Investment Research
April 14, 2023
Alvotech (ALVO) Declines on CRL for Humira's Biosimilar Candidate
Alvotech's shares decline as it receives a complete response letter for biosimilar candidate, AVT02, treating autoimmune disorders. more_horizontal
By GlobeNewsWire
March 17, 2023
Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting
Alvotech ( NASDAQ: ALVO ), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, to more_horizontal
By GlobeNewsWire
February 27, 2023
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
REYKJAVIK, Iceland, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture more_horizontal
By The Motley Fool
December 8, 2022
Why Shares of Alvotech Jumped This Week
The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe. more_horizontal